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Abstract-The isolation and characterization of a plasma membrane preparation from rat heart is 
described. Enzymatic, chemical, and electron microscopic analysis revealed a relative lack of contami- 
nation with nuclear, mitochondrial, ribosomal, and sarcoplasmic reticulum membrane. One calcium 
binding site (I& = 265 pM, B,,, = 65 nmoIes/mg protein) was detected by equilibrium diaiysis. Mono- 
valent metal ions exhibited ItSlOO-fold less inhibition potency than divalent metal ions when analyzed 
by competitive inhibition of calcium binding. The range of K, values found for divalent metal ions 
was similar to the K, value for calcium. La+3 produced a potent non-competitive inhibition, A large 
variety of structural analogues of d,l-propranolol, many of which have been shown to lack B-adrenergic 
blocking activity, were competitive inhibitors of the calcium binding activity, with Ki values ranging 
from 40-W pM. Electrophilic, hydrophobic, and diamino substituents greatly increased the inhibitory 
activity. There was no significant difference between related tertiary and quaternary amines. The experi- 
mental antiarrhythmic agent UM 272 had the least ability to inhibit calcium binding to the cardiac 
plasma membrane preparation (Ki = 795 PM). However, UM 424, another experimental antiarrhythmic 
agent, had an inhibitory activity similar to df-propranolol (Ki = 115pM and 108pM, respectively), 
There has been a considerable amount of speculation 
about the identity and location of the intracellular 
membrane storage sites which serve to release large 
amounts of calcium into the cytoplasm immediately 
after the depolarization of the cardiac plasma mem- 
brane (sarcolemma). G. A. Langer [l, 21 has postu- 
lated that subsarcolemma stores of calcium serve as 
the rapid release sites which contribute to the pool 
of “contractile dependent” calcium. This intermediate 
region of calcium binding sites, which may include 
the external lamina and T tubule membrane systems, 
would be in rapid equilibrium with the pool of extra- 
cellular calcium. Calcium release could be triggered 
by the increased influx of extracellular sodium or cal- 
cium ions which occurs during and immediately after 
the membrane depolarization event. Calcium would 
be transferred into the cytoplasm, to activate myofi- 
bril contraction, by a proposed el~troneutral calcium 
exchange process. 
The proposed role of the cardiac plasma membrane 
as an ion exchange region of the cell has received 
additional attention in pharmacological research 
designed to determine the mechanism of action of 
membrane active drugs, including local anesthetics, 
/I-adrenergic antagonists and antiarrhythmic agents 
[3]. Local anesthetic agents interfere with membrane 
depolarization by displacement of calcium from 
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anionic binding sites on the cell membrane [4]. 
j?-Adrenergic antagonists, such as ~I-propranolol, 
have been found to significantly decrease calcium ac- 
cumulation into sarcoplasmic reticulum [S]. The abi- 
lity of antiarrhythmic agents to prolong the atrioven- 
tricular electrical conduction time and prolong the 
effective refractory period may be related to decreases 
in sodium and potassium conductance across the 
plasma membrane [6-81. The effects of these com- 
pounds on calcium conductance are unknown. 
Madeira et al. [9] have previously demonstrated the 
ability of selected local anesthetic agents to competi- 
tively inhibit calcium binding to rabbit skeletal 
muscle plasma membrane. However, a critical evalu- 
ation and comparison of the ability of the various 
types of membrane-active organic amines, to inhibit 
calcium binding to purified preparations of cardiac 
plasma membrane, has not been previously presented. 
Furthermore, the recent development of a new cate- 
gory of antiarrhythmic agents by Lucchesi and co- 
workers [6-S], which do not exhibit local anesthetic 
or /I-adrenergic antagonist activity, provide a unique 
opportunity to determine if the action of these com- 
pounds includes a direct effect on calcium ion meta- 
bolism in cardiac plasma membrane. 
This communication will describe the isolation of 
a preparation of rat heart plasma membrane, using 
relatively mild, low ionic strength buffer conditions. 
A comparison of the ability of a wide variety of struc- 
tural analogues of di-propranolol to inhibit the cal- 
cium binding activity of the plasma membrane prep- 
aration will be presented. 
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MATERIALS AND METHODS 
Female rats (180-250 g) were obtained from Holtz- 
man CO., Madison, WI. [45Ca]calcium chloride was 
purchased from New England Nuclear Corp. (400 Ci/ 
mole). The experimental antiarrhythmic and anesthe- 
tic drugs were synthesized in the laboratory of Dr. 
R. E. Counsell. Department of Medicinal Chemistry, 
University of Michigan. Each compound was pre- 
pared as the iodide or chloride salt, in a racemic mix- 
ture of the di isomers. The chemical structures were 
verified by nuclear magnetic resonance and infrared 
analysis (R. E. Counsell, personal communication). 
Quinidine HC1, procaine HCI. tetracaine liC1. dl-pro- 
pranolol. ouabain, and carbamylcholine were pur- 
chased from Sigma Chemical Co. Dibucaine HCI was 
obtained from K & K Laboratories. Plainview, NY. 
Lanthanum chloride was obtained from Apache 
Chemicals, Rockford, IL. All other biochemicals were 
purchased from Sigma Chemical Co. 
Isolation of plasma membranes. The method for iso- 
lation of rat heart plasma membranes were based on 
procedures described by Carvalho et ~71. [lo], Rosen- 
thal et al. [ll] and Zacks et al. Cl-?, 131. Freshly 
excised rat (female) hearts were rinsed and minced 
in homogenization buffer containing 50mM CaC12, 
1OmM histidine-Tris-HCl at pH 7.6. The tissue was 
homogenized for 45sec in a Br~nkmann Polytron 
(PCV-2) set at speed 4.5. The homogenate w&s filtered 
through a stainless steel screen (406 micron mesh). 
and the filtrate was allowed to stand for 1 hr 
at 4’. The mixture was centrifuged for 1 min at 272 9. 
The pellet was resuspended in l0mM histidine-Tris- 
HCI pH 7.6 with a motor driven teflon homogenizer 
and centrifuged as before. This process was repeated 
until the supernatant solution was colorless and free 
from protein. The membranes were resuspended in 
ice cold deionized water that was neutralized to pH 
7.8 with a few grains of Tris. After 30min at 4’ the 
membranes were collected by centrifugation for 5 min 
at 272~. The water treatment was repeated once. In 
some cases. the preparation was exposed to IOmM 
histidine-Tris-HCI pH 7.6 containing 1.2 M KC1 for 
10 min at 4’. The membranes were collected by centri- 
fugation at lO.OOOg for 30 min and resuspended in 
1OmM histidine-Tris-HCI pH 7.6 containing 0.25 M 
sucrose. The membrane suspension was layered on 
top of a discontinuous sucrose gradient containing 
equal volumes of 0.3 M/l.32 M/1.7.5 M sucrose. After 
centrifugation for 2 hr at 76,400~ (Beckman SW 41 
rotor), the plasma membrane fraction was collected 
at the 1.32 M/l.75 M interface. The membranes were 
washed once and resuspended in 1OmM histidine- 
Tris-HCI pH 7.6 containing 0.25 M sucrose. Indivi- 
dual 0.5-1.0 ml aliquots (5-10 mg protein/ml) were 
stored at -4o-’ for periods up to 2 months. 
Getteral methods. Protein concentration was deter- 
mined by the method of Lowry et al. [14] with bovine 
serum albumin as the reference standard. DNA was 
determined by the method of Richards [l5] with sal- 
mon sperm DNA as the reference standard. Choles- 
terol was determined by the method of Kirkpatrick 
et al. [16]. Total membrane lipids were extracted 
according to the method of Folch et al. 1171. Lipid 
phosphorous was determined as described previously 
[18]. Succinate Dehydrogenase activity was measured 
according to Slater and Planterose [19]. 5’-AMP 
Nucleotidase activity was measured by the method 
of Heppel and Hilmore [20]. Mg-ATPase activity was 
measured in the presence of 5.0mM MgCI?, 5.0mM 
ATP. 0.1 mM EGTA, O.OS’?, sodium azide. and 
25mM Tris-maleate buffer pH 6.7. After incubation 
at 37.‘. the inorganic phosphate released was deter- 
mined by the method of Sanui [2l]. The calcium 
stimulated Mg-ATPase was determined by adding 
0.1 mM CaCI, to the Mg-ATPase incubation mixture. 
Ca-ATPase activity was measured in the presence of 
5.0mM CaCl,. 5.0 mM ATP. 0.05”, sodium azide. 
and 25 mM Tris-maleate buffer pH 6.7. 
Calcium binding and culcium tiptake ana&s b) 
~if~~pure~~?r~~~o~. Calcium binding was measured by 
incubating plasma membranes for 5 min at 37 in the 
presence of 0.1 mM 4sCaCl, (sp. act. = 10,000_15,ooO 
cpm/nmole), 5 mM ATP. 5 mM MgCl?, O.OSy,; sodium 
azide. and 25 mM Tris-maleate buffer pH 6.5. After 
the incubation. a 200~1 aliquot was withdrawn and 
applied to a 25 mm diameter Millipore filter (Type 
GS, 0.22 pm pore size). The filter was washed with 
5.0ml ice-cold 25 mM Tris+maleate buffer (pH 6.7). 
The amount of 4”Ca retained by the membrane 
sample was measured by liquid scintillation in 10 ml 
Aquasol (New England Nuclear). The amount of 45Ca 
retained by filters without added membrane sample 
was equivalent to the instrumental background 
counting rate. Calcium uptake was measured by 
adding 5 mM potassium oxalate to the calcium 
binding incubation mixture. 
Calcium binding analysis by equilibrium dialysis. 
Calcium binding to plasma membranes in the absence 
of MgATP-” was measured by equilibrium dialysis, 
using an 8 chamber dialysis block (Bel-Art Model 
375), with 0.5ml volume per half chamber. One side 
of each chamber was filled with 0.3 ml of 50mM 
Tris-HCI pH 7.0 containing 0.2-0.4mg of plasma 
membrane protein. The opposite side of each dialysis 
,chamber contained 0.3 ml 45CaCl, (sp. act. = 
10,00&15,000 cpm/nmole) dissolved in deionized 
HZ0 at a concentration of 16.4-316~M. In 
experiments designed to measure the ability of an 
‘inhibitor to prevent calcium binding, the agent was 
added to the CaCl, side of the dialysis chamber at 
a final concentration of O.l-l.OmM. In all cases, the 
final volume of each dialysis chamber was 0.6 ml. The 
two halves of the dialysis block were separated by 
a single sheet of cellulose dialysis membrane 
(5 x 5 cm; Be1 Art No. 299). previously soaked 
overnight in deionized water. Dialysis was performed 
by vertical rotation for 24 hr at 4- at a constant speed 
of 10 RPM (Scientific Industries Rotator, Model 150). 
Duplicate aliquots of lOO$ were removed from each 
half chamber with a lOO$ Eppendorf pipet and the 
amount of radioactivity was measured by liquid 
scintillation. Control experiments revealed that 
calcium equilibrium was estadlished after 20 hr at 4 ‘. 
Equivalent binding results could be obtained if 45Ca 
was initially added to either half of a dialysis 
chamber. The average variance from true equilibrium 
was 4.8 per cent. In order to minimize the effect of 
this variability, the total concentration of protein and 
calcium were arranged so that the amount of calcium 
bound was Z- 25 per cent of the total calcium 
con~ntration. 
Calcium binding to rat heart plasma membrane 
Calcium binding constants were determined 
according to Klotz et al. [22]. In this method the 
inverse amount of calcium bound to 1 mg of plasma 
membrane protein was plotted versus the inverse 
concentration of unbound calcium in the equilibrated 
sample. Normally, 4-6 individual data points were 
used to construct a single plotted line. Each 
experimental plot of data points was considered 
acceptable if the linear correlation coefficient was 
greater than 0.95, as calculated by the least squares 
method of linear analysis. 
Calcium binding inhibition analysis was performed 
according to the slope-intercept method described by 
Dixon and Webb [23]. A competitive type of 
inhibition of calcium binding produces an apparent 
increase in the calcium dissociation constant. The 
inhibition constant (K, competitive) can be calculated 
from the interception point of the plotted lines on 
the calcium concentration axis, according to the 
equation Ki = [i]/[(K,,, t Kd) - 11. In this case, the 
point of interception of the two lines (with and 
without added inhibitor) on the l/E axis must be 
identical. For the experiments described in this 
communication, the maximum acceptable deviation 
from a true interception of the least squares linear 
plots was _t 10 per cent. A noncompetitive type of 
inhibition produces an apparent decrease in the 
maximum amount of calcium bound. The inhibition 
constant (K, noncompetitive) can be calculated from 
the interception point of the plotted lines on the l/B 
,axis, according to the equation Ki = [i]/[(&,,, + 
B,,,) - 11. In this case. the maximum acceptable 
deviation from a true interception of the least squares 
linear plots on the calcium axis, was +lO per cent. 
Electron microscopy. Electron microscopy was 
performed by Dr. Sun-Kee Kim at the Veterans 
Administration Hospital, Ann Arbor, Michigan. 
Plasma membrane was pelleted by centrifugation 
at 10,000 g for 30 min and fixed in 0.1 M sodium 
phosphate buffer (pH 7.4) containing 1% 
paraformaldehyde and 1.47; glutaraldehyde. After 
several rinses with phosphate buffer and overnight 
storage in buffer containing 0.2 M sucrose, the pellets 
were post-fixed in phosphate buffer containing l”/ 
Osmium tetroxide for 1 br and then stained with 0.5% 
uran)l acetate according to Karnovsky [24]. The 
stained pellets were dehydrated and embedded in 
Epon as described by Luft [25]. Sections of 700A 
thickness were cut on a Porter-Blum (MT IIB) 
microtome and stained with uranyl acetate according 
to Venable and Coggeshall [26]. The sections were 
examined in a Hitachi IIC electron microscope 
operated at 75 KV. 
RESULTS 
Properties of plasma membrane preparations 
Chemical and enzyme analysis. Approximately 20 
per cent of the initial amount of protein in the 
homogenate was recovered in the plasma membrane 
preparation. Approximately 37 per cent of the initial 
amount of cholesterol was recovered with a 
cholesterol/phospholipid ratio of 0.33, compared to 
a ratio of 0.25 in the homogenate. Less than 10 per 
cent of the initial activity of succinate dehydrogenase 
was recovered in the membrane preparation. 
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Fig. 1. Analysis of calcium binding and calcium transport 
in purified rat heart plasma membrane by Millipore filtra- 
tion. Calcium binding and calcium transport activities were 
measured as described in Methods. Each incubation mix- 
ture contained 0.1 mM 45CaC12 (sp. act. = 10,00&15,000 
cpm/nmole), 0.64 mg plasma membrane protein per ml of 
assay mixture, 25 mM Tris-maleate buffer pH 6.7, 0.05% 
sodium azide, and the following specific additions: 
Mg-ATP, 5 mM and oxalate, 5 mM _: oxalate, 
5mM -m-m--; Mg-ATP, 5mM -c+u-; no addi- 
tion, -A-A-. 
However, 30 per cent of the initial 5’-AMP 
nucleotidase activity was recovered in the final 
preparation. 
Calcium binding and transport activities of the 
plasma membrane preparation were not stimulated 
by MgATP-’ (Fig. 1). Furthermore, MgATPw2 
caused a slight inhibition of calcium binding. 
Measurements of calcium transport in cardiac 
sarcoplasmic reticulum are typically performed only 
in the presence of MgATP-’ [27,28], as the rate of 
transport in the presence of oxalate, without 
MgATP-’ is minimal. This result has also been 
verified in our laboratory. Using a preparation of 
sarcoplasmic reticulum from dog heart [28], 
MgATP-’ produced a 7-fold stimulation of calcium 
binding (oxalate absent) and a 500-fold stimulation 
of calcium transport (oxalate present). These 
MgATP-’ stimulated activities are well documented 
indicators of sarcoplasmic reticulum function [27,28]. 
Measurements of the various plasma membrane 
ATPase activities are presented in Fig. 2. The 
addition of low concentrations of calcium produced 
a maximum 1.5-fold increase of the Mg-ATPase 
activity, an effect similar to that observed in 
preparations of sarcoplasmic reticulum [27]. This 
calcium stimulated, Mg-ATPase is thought to be 
specifically located ins>rcoplasmic reticulum [29] 
and the enzyme activity reported by Sulakhe et al. 
[27] is 20 times greater than that observed with the 
plasma membrane preparation. The Ca-ATPase 
activity was 8 times more active than the Mg-ATPase 
activity; whereas, in sarcoplasmic reticulum 
membrane, the Ca-ATPase was less active than the 
Mg-ATPase [27]. The Ca-ATPase activity in plasma 
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Fig. 2. Analysis of ATPase activities in rat heart plasma 
membranes. The ATPase activities were measured as de- 
scribed in Methods. Each incubation mixture contained 
0.13 mgiml plasma membrane protein, 35 mM Tris- 
maleate buffer pH 6.7. 0.05pb sodium azide, 100 $M ethyl- 
ene~lycoi-his-(~-aminoethyl ether) N,,~~‘-tetraa~eti~ acid 
(EC%A). and -the follow&g additions: &3GQpM CaQ, 
I mM M&l,. and 1 mM ATP (Calcium activated Ma- 
ATPase) 1-m--m-; O-5 mM MgClz and 5 mM ATP (Mg- 
ATPase) --tt. O-5 mM CaCI, and 5 mM ATP (Ca- 
ATPase) --i>--o-. The concentration of calcium not 
complexed with EGTA ([Ca+‘]free) was calculated 
according to Owen [41]. 
membrane is thought to be involved in promoting 
calcium transport across the cell membrane [30,31]. 
The results obtained from measurements of ATPase 
activities and calcium binding and uptake activities 
indicate that the plasma membrane preparation is 
relatively uncontaminat~ by sarcoplasmic reticulum 
membrane. 
Electron microscopy. A careful analysis of a large 
series of individual photographs from an electron 
microscopic examination of the preparation indicated 
a relative absence of nuclei, mitochondria and rough 
endoplasmic reticulum. The presence of sarcoplasmic 
reticulum vesicles cannot be distinguished from 
plasma membrane vesicles by this technique. A 
significant amount of adsorbed contractile myofibrils 
was observed at lower magnification. A large number 
of cell junctions, or intercalated disks, were also 
observed in the preparation. Hui ef af. [30] have 
recently described a procedure for isolating plasma 
membranes from guinea pig heart which includes 
extraction with KCI. This treatment caused the 
disruption and removal of the adsorbed contractile 
proteins. When our plasma membrane preparation 
was extracted with 1.25 M KC1 as described by Hui 
et al. [30]. a significant amount of the adsorbed 
myofibrils were removed, as determined by electron 
microscopy. Zacks e-1. [12] and Vandenburg et al. 
[13] have recommended against extraction with 
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Fig. 3. Klotz plot analysis of calcium binding to rat heart 
plasma membranes measured by equilibrium dialysis. Cal- 
cium binding activity was measured by equilibrium dialy- 
sis, as described in Methods. The final plasma membrane 
protein concentration was 1.91 mgjml on the sample side 
of the dialysis membrane. 
removing the external lamina layer and loosely bound 
extrinsic proteins. In fact, Hui et al. [30] reported 
significant losses of Na+K+-ATPase activity (78 per 
cent), 5-Nucleotidase activity (76 per cent), and 
Adenylate Cyclase activity (45 per cent) after 
extraction with 1.2 M KCI. For these reasons, we 
chose to omit the extraction process from our 
isolation procedure. 
Measurement of calcium binding 
Equilibrium dialysis was used to determine the 
extent of calcium binding to the plasma membrane 
preparation. In the calcium concentration range 
normally employed in these studies (16-416 PM), only 
one type of calcium binding site could be detected 
(Fig. 3). From a series of 4 independent membrane 
preparations. the average calcium dissociation 
constant (KJ was 265 k 61 FM. and the average 
maximum calcium binding capacity (B,,,) was 
65 _+ 1.4 nmoles/mg protein. As plotted according to 
Klotz et al. [Zj, this result indicates that this class 
of calcium binding sites would be one-half saturated 
at a free calcium concentration of 0.26 mM. 
Therefore, this class of binding sites would be greater 
than 80 per cent saturated when exposed to l.OmM 
Ca+*, the concentration normally found in 
extracellular fluids [32]. 
An analysis of calcium binding to a plasma 
membrane preparation treated with 1.25 M KCI, 
according to Hui er al. [30] indicated that the binding 
capacity for calcium was 2.4 times greater than the 
binding capacity of plasma membrane prepared in the 
absence of KCl. However, the I(, values were similar 
in both preparations. Thus, the KC1 treatment 
apparently removes protein material which does not 
significantly contribute to the calcium binding of the 
plasma membrane. 
Inhibition of calcium binding by other metal ions 
All of the divalent metal ions produced a 
competitive inhibition within a concentration range 
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Table 1. Inhibition of calcium binding to rat 













* Calcium binding activity was measured 
as described in Methods. All inhibitors were 
competitive except LaCl,, which was non- 
competitive. The dissociation constant (K,,) 
for CaCl, was 0.26 + 0.06 mM (4 determina- 
tions). 
approximately equivalent to the dissociation constant 
of calcium (Table 1). Monovalent metal ions were 
considerably less active competitive inhibitors of 
calcium binding. Whereas K+. Li+, and Rb+ 
possessed approximately the same inhibitory activity, 
Na+ was significantly less potent (Ki = 33.5). The 
trivalent metal ion. La+3, caused a potent 
noncompetitive inhibition of calcium binding. Langer 
[Z] found that La +3 is an impermeable ion, yet it 
can specifically uncouple the cardiac membrane 
action potential from muscle contraction by 
displacing Ca+’ from cell surface binding sites. Thus, 
the noncompetitive inhibition of Ca+* binding 
observed in our studies may reflect a unique 
membrane interaction of this trivalent cation. 
Inhibition of calcium binding h) potential 
antiarrhythmic and anesthetic agents 
The results of experiments designed to measure the 
ability of a series of structural analogues of 
DL-propranolol to inhibit the calcium binding activity 
Table 2. Inhibition of calcium binding to rat heart plasma membrane by antiarrhyth- 
mic and anesthetic agents* 
Series I Series II , Series III 
Q&p x&Tf< I$jT’ 
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* Calcium binding activity was measured as described in Methods. Inhibition was 
competitive (C) or non-competitive (N-C) 
2288 D. A. FELDMAK and P. A. WFIWHOLD 
of the plasma membrane preparation are presented 
in Table 2. The results are organized in an attempt 
to facilitate comparisons of the effects of a related 
group of drug structures, differing by substitutions at 
a single position. The quaternary nitrogen derivative 
of propranolol, UM 272, is much less inhibitory than 
propranolol. However, UM 282, which differs from 
UM 272 by a phenyl group substitution, is more 
inhibitory than propranolol. The results of studies 
with compounds listed in Series II, demonstrate that 
a potent competitive inhibition of calcium binding 
can be achieved with a quaternary amine when the 
phenoxyl group is substituted with a phenyl group 
or iodine. Relatively less inhibition was produced by 
the methyl or hydrogen substituted analogues. The 
results of compounds listed in series III demonstrate 
that a tertiary substituted nitrogen atom (UM 329) 
is equivalent to a quaternary substituted nitrogen 
atom (UM 301) when calcium inhibition activities are 
compared. A nitrogen atom with a lower degree of 
substitution will produce less inhibition. 
The local anesthetic dibucaine and the 
antiarrhythmic agent quinidine behaved similar to the 
majority of the experimental drug structures. 
Carbamylcholine. an analog of acetylcholine, 
exhibited almost 10 times more inhibitory activity 
than choline. Ouabain, a cardiac glycoside inhibitor 
of the Na+K’ ATPase, was relatively ineffective. 
DISCUSSION 
Equilibrium dialysis was used to determine the 
parameters of calcium binding to the rat heart plasma 
membrane preparation. Only one calcium binding site 
was detected CK, = 265 PM. B,,, = 65 nmoles/mg 
protein). A survey of the scientific literature reveals 
a broad diversity of calcium binding activities among 
plasma membrane preparations from a wide variety 
of animal tissues. The presence of only one calcium 
binding site was detected by Madeira and Carvalho 
[S] with rabbit skeletal muscle (I& = 40pM, 
- 40nmoles/mg) and by Schlatz and Marinetti 
$ii with rat liver (& = 200pM). The presence of 
two calcium binding sites was detected by Madeira 
and Antunes-Madeira [34] with sheep brain 
(& = 0.87pM, 74pM). by Shami et al. [35] with 
guinea pig placenta (I& = 31 PM, 1.1 mM). and by 
Hemminki [36] with rat brain (Kd = 360pM, 
27mM). It must be assumed that the measurement 
of these unique calcium binding activities is 
dependent upon the particular method of plasma 
membrane isolation and the range of calcium ion 
concentration that is selected. 
A simple comparison of calcium binding affinities 
and binding capacities does not provide a sufficient 
basis for an assessment of the expected biological 
properties of plasma membrane preparations. 
Therefore, an extensive series of inhibition 
measurements, using metal ions and experimental 
membrane active agents, were performed to more 
fully characterize the calcium binding properties of 
the rat heart plasma membrane preparation. A wide 
variety of monovalent metal ions exhibited 
lGlOO-fold less inhibition potency than divalent 
metal ions as determined by a comparison of 
competitive inhibition Ki values. Furthermore. the 
range of Ki values found for the divalent metal ions 
was very similar to the calcium K, value. These 
results suggest the absence of a large number of 
specific metal ion binding sites which can select a 
divalent cation by its characteristic ionic radius and 
electron charge density. Instead. the plasma 
membrane apparently contains a large region of 
anionic sites which can discriminate the net ionic 
charge of a cation, in this case exhibiting a greater 
preference for divalent cations than for sodium or 
potassium ions. This property may be important in 
the cardiac plasma membrane since this membrane 
is directly involved in regulating the flux of metal 
ions in the cardiac conduction-contraction cycle 
Il. 21. 
Seeman [3] and Papahadjopoulos 1377 have 
recently presented extensive reviews of scientific 
literature which support the concept that plasma 
membrane phosphohpids serve as the site of metal 
ion and local anesthetic agent binding. Furthermore, 
the displacement of metal ions bound to acidic 
phospholipids is believed to be the primary 
mechanism of anesthetic action. The studies described 
in this communication demonstrate that a variety of 
structural analogues of DL-propranolol can displace 
calcium from binding sites on rat cardiac plasma 
membranes. The inhibitory potencies of the 
compounds tested were estimated by determining 
inhibition constants (KJ. Specifically. a 50 per cent 
inhibition would be expected to occur if these agents 
were present at a concentration equal to twice the 
competitive K, value when the calcium concentration 
is equal to the dissociation constant (KJ). 
Electrophilic and (or) hydrophobic substituents on 
the phenoxy ring system or on the isopropylamine 
group generally increased the inhibitory activity of 
the compound. Diamino substituted agents were 
more potent inhibitors than related monoamino 
structures. This may explain the ability of 
carbamylcholine to displace calcium at one-tenth the 
concentration required for choline. Tertiary amines 
(UM 329) were slightly more potent inhibitors of 
calcium binding than the related primary and 
secondary amines (UM 312. UM 284). However. there 
was no significant difference between the effects of 
related tertiary and quaternary amines (UM 329. UM 
301). Sheetz and Singer 1381 have speculated that 
quaternary amines cannot readily permeate through 
a cell mambrane to reach the cytoplasmic side. Thus. 
the quaternary amine agents, and possibly the other 
less substituted isomers, may be acting to 
competitively inhibit the binding of calcium to 
external sites on the plasma membrane. The potent 
inhibition of calcium binding caused by UM 282 may 
be due to its unique amphipathic structure. This agent 
possesses two aromatic groups separated by a 
quaternary substituted nitrogen atom. Sheetz and 
Singer 1383 have proposed that the hydrophobic end 
of a local anesthetic agent penetrates into the 
nonpolar lipid bilayer region of the membrane. Thus. 
UM 282 would possess two hydrophobic groups for 
an enhanced interaction with the lipid bilay’er of the 
membrane. This association would permit the 
cationic amino group to interact with anionic sites 
at hydrophilic regions of the membrane. This 
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compound provides an interesting prototype for the 
design of future membrane active agents. 
The concentrations required to produce a 
significant inhibition of calcium binding to the plasma 
membrane preparation fall within the approximate 
range of 100-4OO~M. These concentrations may be 
higher than would be required to achieve inhibition 
in uivo especially since the local concentration of a 
drug at membrane binding sites may be much higher 
than that in free circulation [8,39,40]. In fact, 
Kniffen et ai. [8] have observed that there is a poor 
correlation between the plasma concentration and the 
therapeutic effectiveness of quaternary ammonium 
antiarrhythmic agents, because myocardial tissue 
appears to concentrate these compounds. Thus, while 
the con~ntratio~ required to achieve inhibition of 
calcium binding as determined in these studies may 
serve as a relative indication of the inhibition potency, 
the-results do not indicate the thera~utic dose which 
would be required to elicit this effect in uiuo. 
We have shown that DL-propranolol. UM 212, and 
UM 424 have widely differing abilities to 
competitively inhibit the calcium binding activity of 
the plasma membrane preparation. B. R. Lucchesi 
and coworkers have presented a series of 
communications C4-81 which describe the 
antiarrhythmic properties of these compounds. When 
DL-propranolol, UM 272. and UM 424 were used to 
reverse ouabain-induced arrhythmia in live dogs, an 
average dose of 6.1, 3.0, and 4.6mg drug/kg body 
weight (respectively) was required to restore and 
maintain a nor&al sinus rhythm for a period of at 
feast 30min. In comparison, the corresponding Ki 
values for inhibition of calcium binding, as 
determined in the present study, are 108, 795 and 
115 PM. Thus, the most potent antiarrhythmi~ agent 
(UM 272) has the least ability to inhibit calcium 
binding to cardiac plasma membrane. This low 
activity for competitive inhibition may be another 
desirable characteristic of this agent. in addition to 
the previously described [7] lack of anesthetic and 
fi-adrenergic blocking activities. The relative inability 
of an antiarrhythmic agent to inhibit calcium binding 
would avoid the undesirable side-effects (depression 
of myocardial contractility) encountered with some 
antiarrhythmic agents [39]. 
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